DCF — OVERLAKE HOSPITAL MEDICAL CENTER
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-463.0M
PV of Cash Flows
$-1.0B
PV of Terminal Value
$-1.7B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $695.4M | $-97.1M | -14.0% | $-126.5M | $-115.0M |
| Year 2 | $716.2M | $-92.8M | -13.0% | $-123.1M | $-101.8M |
| Year 3 | $737.7M | $-88.2M | -12.0% | $-119.5M | $-89.7M |
| Year 4 | $759.9M | $-87.1M | -11.0% | $-119.2M | $-81.4M |
| Year 5 | $782.7M | $-87.7M | -11.0% | $-120.9M | $-75.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$675.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14458961992962072
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5